Sartorius Stedim Biotech Shares Drop by 4.5% and Fall Below its 50-Day Moving Average
The French bioproduction equipment specialist faces a sharp setback mid-morning. After several sessions of recovery, the stock abruptly breaks with the momentum established since mid-May and slips to the bottom of the SBF 120, in an otherwise positive Parisian market.
The stock is among the sharpest declines in the SBF 120
Sartorius Stedim Biotech shares lose 4.24% to €169.20, down from a close of €176.70 the previous day. The decline places the stock among the sharpest falls in the SBF 120, even as the index gains 0.31% during the session and the CAC 40 rises by 0.37%. This movement contrasts with the bullish sequence of the past few weeks, which had brought the stock close to €183.70 two sessions ago. The weekly performance now stands at -5.26%, while the monthly performance remains positive at 8.5%.
The decline diminishes recent gains and falls below the 50-day moving average (€171.02)
Today's drop brings the share price below its recently reclaimed 50-day moving average (€171.02), now sitting 1.1% below this technical threshold. The 20-day moving average at €176.09 is also breached, with the share price now 3.9% below it. The RSI at 55 remains neutral, suggesting that the decline comes from a zone of balance rather than from an overly bullish excess. The support at €155.90 provides the next identified lower boundary, while the resistance at €183.70, frequently contested in recent weeks, continues to act as a ceiling. Over the year, the stock is still down by 14.5%.
